{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T06:52:33Z","timestamp":1777099953284,"version":"3.51.4"},"reference-count":46,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2011,6,29]],"date-time":"2011-06-29T00:00:00Z","timestamp":1309305600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0021712","type":"journal-article","created":{"date-parts":[[2011,6,29]],"date-time":"2011-06-29T21:08:02Z","timestamp":1309381682000},"page":"e21712","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":25,"title":["Ras Inhibition Induces Insulin Sensitivity and Glucose Uptake"],"prefix":"10.1371","volume":"6","author":[{"given":"Adi","family":"Mor","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeta","family":"Aizman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacob","family":"George","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoel","family":"Kloog","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2011,6,29]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.2337\/diabetes.37.12.1595","article-title":"Banting lecture 1988. Role of insulin resistance in human disease.","volume":"37","author":"GM Reaven","year":"1988","journal-title":"Diabetes"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"773","DOI":"10.2337\/db09-9028","article-title":"Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus.","volume":"58","author":"RA Defronzo","year":"2009","journal-title":"Diabetes"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1210\/en.2006-0692","article-title":"Interleukin-1beta-induced insulin resistance in adipocytes through down-regulation of insulin receptor substrate-1 expression.","volume":"148","author":"J Jager","year":"2007","journal-title":"Endocrinology"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1172\/JCI117936","article-title":"Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance.","volume":"95","author":"GS Hotamisligil","year":"1995","journal-title":"Journal of Clinical Investigations"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"7060","DOI":"10.1074\/jbc.M509782200","article-title":"Direct cross-talk of interleukin-6 and insulin signal transduction via insulin receptor substrate-1 in skeletal muscle cells.","volume":"281","author":"C Weigert","year":"2006","journal-title":"Journal of Biological Chemistry"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/39335","article-title":"Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function.","volume":"389","author":"KT Uysal","year":"1997","journal-title":"Nature"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1007\/s00125-008-0998-8","article-title":"Overexpression of Il6 leads to hyperinsulinaemia, liver inflammation and reduced body weight in mice.","volume":"51","author":"S Franckhauser","year":"2008","journal-title":"Diabetologia"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/nm1185","article-title":"IKK-beta links inflammation to obesity-induced insulin resistance.","volume":"11","author":"MC Arkan","year":"2005","journal-title":"Nat Med"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/S0899-9007(01)00747-X","article-title":"Obesity, metabolic syndrome X, and inflammation.","volume":"18","author":"UN Das","year":"2002","journal-title":"Nutrition"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.2337\/diabetes.51.7.2005","article-title":"Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IkappaB-alpha.","volume":"51","author":"SI Itani","year":"2002","journal-title":"Diabetes"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"41294","DOI":"10.1074\/jbc.M406514200","article-title":"Fatty acid-induced insulin resistance in L6 myotubes is prevented by inhibition of activation and nuclear localization of nuclear factor kappa B.","volume":"279","author":"S Sinha","year":"2004","journal-title":"Journal of Biological Chemistry"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1210\/en.2005-0440","article-title":"Palmitate induces tumor necrosis factor-alpha expression in C2C12 skeletal muscle cells by a mechanism involving protein kinase C and nuclear factor-kappaB activation.","volume":"147","author":"M Jove","year":"2006","journal-title":"Endocrinology"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"35279","DOI":"10.1074\/jbc.M706762200","article-title":"A subpopulation of macrophages infiltrates hypertrophic adipose tissue and is activated by free fatty acids via Toll-like receptors 2 and 4 and JNK-dependent pathways.","volume":"282","author":"MT Nguyen","year":"2007","journal-title":"Journal of Biological Chemistry"},{"issue":"2","key":"ref14","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0092-8674(00)00115-X","article-title":"Ras and Rho GTPases: a family reunion.","volume":"103","author":"D Bar Sagi","year":"2000","journal-title":"Cell"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/366643a0","article-title":"Proteins regulating Ras and its relatives.","volume":"366","author":"MS Boguski","year":"1993","journal-title":"Nature"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0092-8674(00)00115-X","article-title":"Ras and Rho GTPases: a family reunion.","volume":"103","author":"D Bar-Sagi","year":"2000","journal-title":"Cell"},{"key":"ref17","first-page":"4682","article-title":"ras oncogenes in human cancer: a review.","volume":"49","author":"JL Bos","year":"1989","journal-title":"Cancer Res"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0959-437X(98)80061-0","article-title":"Ras signalling and apoptosis.","volume":"8","author":"J Downward","year":"1998","journal-title":"Curr Opin Genet Dev"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"5488","DOI":"10.1128\/MCB.21.16.5488-5499.2001","article-title":"Oncogenic Ras blocks anoikis by activation of a novel effector pathway independent of phosphatidylinositol 3-kinase.","volume":"21","author":"A McFall","year":"2001","journal-title":"Mol Cell Biol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"599","DOI":"10.4161\/cbt.306","article-title":"Ras family signaling: therapeutic targeting.","volume":"1","author":"AD Cox","year":"2002","journal-title":"Cancer Biol Ther"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1042\/BST0330657","article-title":"Compartmentalized signalling of Ras.","volume":"33","author":"MR Philips","year":"2005","journal-title":"Biochem Soc Trans"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0076-6879(07)00432-6","article-title":"The Ras inhibitor farnesylthiosalicylic acid (Salirasib) disrupts the spatiotemporal localization of active Ras: a potential treatment for cancer.","volume":"439","author":"B Rotblat","year":"2008","journal-title":"Methods Enzymol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1161\/01.CIR.0000016065.90068.96","article-title":"Functional inhibition of Ras by S-trans,trans-farnesyl thiosalicylic acid attenuates atherosclerosis in apolipoprotein E knockout mice.","volume":"105","author":"J George","year":"2002","journal-title":"Circulation"},{"key":"ref24","article-title":"The Ras-pathway inhibitor S,trans-trans farnesythiosalicylic acid (FTS) suppresses experimental allergic encephalomyelitis.","author":"D Karusis","year":"2001"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1046\/j.1365-2249.2001.01674.x","article-title":"Treatment of MRL\/lpr mice, a genetic autoimmune model, with the Ras inhibitor, farnesylthiosalicylate (FTS).","volume":"126","author":"A Katsav","year":"2001","journal-title":"Clin Exp Immunol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1078\/0171-2985-00208","article-title":"Inhibition of ras by farnesylthiosalicylate significantly reduces the levels of autoantibodies in two animal models of the antiphospholipid syndrome.","volume":"207","author":"A Katzav","year":"2003","journal-title":"Immunobiology"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S0960-9822(99)80265-6","article-title":"Induction of NF-kappaB by the Akt\/PKB kinase.","volume":"9","author":"LP Kane","year":"1999","journal-title":"Curr Biol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0925-4439(97)00077-X","article-title":"Stringent structural requirements for anti-Ras activity of S-prenyl analogues.","volume":"1406","author":"Z Aharonson","year":"1998","journal-title":"Biochim Biophys Acta"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ejphar.2010.06.029","article-title":"Ras inhibition attenuates pancreatic cell death and experimental type 1 diabetes: possible role of regulatory T cells.","volume":"643","author":"E Aizman","year":"2010","journal-title":"European Journal of Pharmacology"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1002\/eji.200838292","article-title":"N-Ras or K-Ras inhibition increases the number and enhances the function of Foxp3 regulatory T cells.","volume":"38","author":"A Mor","year":"2008","journal-title":"European Journal of Immunology"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.ejphar.2009.06.001","article-title":"Ras inhibition increases the frequency and function of regulatory T cells and attenuates type-1 diabetes in non-obese diabetic mice.","volume":"616","author":"A Mor","year":"2009","journal-title":"European Journal of Pharmacology"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"19693","DOI":"10.1074\/jbc.M909860199","article-title":"Stimulation of NFkappa B activity by multiple signaling pathways requires PAK1.","volume":"275","author":"JA Frost","year":"2000","journal-title":"Journal of Biological Chemistry"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s10719-007-9075-7","article-title":""Fluorescent glycogen" formation with sensibility for in vivo and in vitro detection.","volume":"25","author":"MC Louzao","year":"2008","journal-title":"Glycoconj J"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.2337\/db09-1805","article-title":"Deletion of Pten in Pancreatic {beta}-Cells Protects Against Deficient {beta}-Cell Mass and Function in Mouse Models of Type 2 Diabetes.","volume":"59","author":"L Wang","year":"2010","journal-title":"Diabetes"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1210\/en.2004-1560","article-title":"Palmitate-induced interleukin 6 production is mediated by protein kinase C and nuclear-factor kappaB activation and leads to glucose transporter 4 down-regulation in skeletal muscle cells.","volume":"146","author":"M Jove","year":"2005","journal-title":"Endocrinology"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/0026-0495(95)90123-X","article-title":"Differential effects of fat and sucrose on the development of obesity and diabetes in C57BL\/6J and A\/J mice.","volume":"44","author":"RS Surwit","year":"1995","journal-title":"Metabolism"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"3923","DOI":"10.1002\/j.1460-2075.1996.tb00766.x","article-title":"Multiple p21ras effector pathways regulate nuclear factor of activated T cells.","volume":"15","author":"E Genot","year":"1996","journal-title":"EMBO J"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0952-7915(00)00089-3","article-title":"Ras regulation and function in lymphocytes.","volume":"12","author":"E Genot","year":"2000","journal-title":"Curr Opin Immunol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-5728(01)00385-X","article-title":"The Ras-pathway inhibitor, S-trans-trans-farnesylthiosalicylic acid, suppresses experimental allergic encephalomyelitis.","volume":"120","author":"D Karussis","year":"2001","journal-title":"J Neuroimmunol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/S1357-4310(00)01789-5","article-title":"RAS inhibitors: potential for cancer therapeutics.","volume":"6","author":"Y Kloog","year":"2000","journal-title":"Mol Med Today"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"173","DOI":"10.2337\/diacare.14.3.173","article-title":"Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease.","volume":"14","author":"RA DeFronzo","year":"1991","journal-title":"Diabetes Care"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/nrm1837","article-title":"Critical nodes in signalling pathways: insights into insulin action.","volume":"7","author":"CM Taniguchi","year":"2006","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/nm1166","article-title":"Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB.","volume":"11","author":"D Cai","year":"2005","journal-title":"Nat Med"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/biof.5520150207","article-title":"Oxidative stress and gene expression: the AP-1 and NF-kappaB connections.","volume":"15","author":"M Karin","year":"2001","journal-title":"Biofactors"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1042\/BST0330354","article-title":"Insulin signal transduction in human skeletal muscle: identifying the defects in Type II diabetes.","volume":"33","author":"M Bjornholm","year":"2005","journal-title":"Biochemical Society Transactions"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.bbamcr.2008.03.009","article-title":"Galectin-3 regulates RasGRP4-mediated activation of N-Ras and H-Ras.","volume":"1783","author":"R Shalom-Feuerstein","year":"2008","journal-title":"Biochim Biophys Acta"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0021712","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,12]],"date-time":"2019-06-12T14:35:59Z","timestamp":1560350159000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0021712"}},"subtitle":[],"editor":[{"given":"Joseph","family":"Najbauer","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2011,6,29]]},"references-count":46,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2011,6,29]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0021712","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,6,29]]}}}